Microalbuminuria is an early marker of target organ damage in essential hypertension

American Journal of Hypertension

Volumn 11, Issue 4 I, 1998, Pages 430-438

  Pontremoli, Roberto ^a   Nicolella, Clizia ^a   Viazzi, Francesca ^a   Ravera, Maura ^a   Sofia, Antonella ^a   Berruti, Valeria ^a   Bezante, Gian Paolo ^a   Del Sette, Massimo ^b   Martinoli, Carlo ^b   Sacchi, Giorgo ^b   Deferrari, Giacomo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Carotid wall thickness; Hypertension; Left ventricular mass; Microalbuminuria; Renal vascular impedance

Indexed keywords

ADULT; AMBULATORY MONITORING; ARTICLE; B SCAN; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ALBUMINURIA; BIOLOGICAL MARKERS; CAROTID ARTERIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; REFERENCE VALUES; REGRESSION ANALYSIS; RENAL CIRCULATION; VASCULAR RESISTANCE;

EID: 0031746230     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00498-6     Document Type: Article

References (54)

1. Pontremoli R, Sofia A, Ravera M, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension the Magic study . Hypertension. 30:1997;1135-1143.
2. Palatini P, Graniero GR, Mormino P, et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension (HARVEST Study). Am J Hypertens. 89:1996;334-341.
3. Agewall S, Persson B, Samuelsson O, et al. Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens. 11:1993;461-469.
4. Mimram A, Ribstein J, DuCailar G, Halimi J-M. Albuminuria in normal and essential hypertension. J Diabetes Complications. 8:1994;150-156.
5. Hoegholm A, Bang LE, Kristensen KS, et al. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension. 24:1994;101-105.
6. James AM, Fotherby MD, Potter JF. Microalbuminuria in elderly hypertensives reproducibility and relation to clinic and ambulatory blood pressure . J Hypertens. 12:1994;309-314.
7. James AM, Fotherby MD, Potter JF. Screening test for microalbuminuria in non diabetic elderly subjects and their relation to blood pressure. Clin Sci. 88:1995;185-190.
8. Summerson JH, Bell RA, Konen JC. Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis. 26:1995;577-579.
9. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron. 61:1992;94-97.
10. Yudkin JS, Forrest RD, Jackson C. Microalbuminuria as predictor of vascular disease in non diabetic subjects. Lancet. ii:1988;530-533.
11. Damsgaard EM, Froland A, Jorgenesen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J. 300:1990;297-300.
12. Lyungman S, Wikstrand J, Hartford M, Berglund G. Urinary albumin excretion - A predictor of risk of cardiovascular disease. Am J Hypertens. 9:1996;770-778.
13. Bianchi S, Bigazzi R, Campese VM. Increased cardiovascular events in patients with hypertension and microalbuminuria (abst). J Am Soc Nephrol. 7:1996;1546.
14. Redon J, Liao Y, Lozano JV, et al. Ambulatory blood pressure and microalbuminuria in essential hypertension role of circadian variability . J Hypertens. 12:1994;947-953.
15. Bianchi S, Bigazzi R, Baldari G, et al. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens. 7:1994;23-29.
16. Giaconi S, Levanti C, Fommei E, et al. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens. 2:1989;259-261.
17. Bianchi S, Bigazzi R, Valtriani C, et al. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension. 23:1994;681-687.
18. Bianchi S, Bigazzi R, Quinones Galvan A, et al. Insulin resistance in microalbuminuric hypertension sites and mechanisms . Hypertension. 26:1995;789-795.
19. Falkner B, Kushner H, Levison S, Canessa M. Albuminuria in association with insulin and sodium-lithium countertransport in young African Americans with borderline hypertension. Hypertension. 25:1995;1315-1321.
20. Bigazzi R, Bianchi S, Baldari D, et al. Microalbuminuria in salt-sensitive patients a marker for renal and cardiovascular risk factors . Hypertension. 23:1994;195-199.
21. Pontremoli R, Cheli V, Sofia A, et al. Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transplant. 10:(suppl 6):1995;6-9.
22. Pedrinelli R, Gianpietro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 344:1994;14-18.
23. Kario K, Matsuo T, Kobajashi H, et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol. 16:1996;455-461.
24. Erley CM, Holzer M, Kramer BK, Risler T. Renal haemodynamics and organ damage in young hypertensive patients with different plasma renin activities after ACE inhibition. Nephrol Dial Transplant. 7:1992;216-220.
25. Pedrinelli R, Lindpainter K, Dell'Oma G, et al. Urinary albumin excretion and atherosclerosis in essential hypertension. Clin Sci. 92:1997;45-50.
26. Parving H-H, Jensen HA, Mogensen CE, Evrin PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet. i:1974;1190-1192.
27. Pontremoli R. Microalbuminuria in essential hypertension - its relation to cardiovascular risk factors. Nephrol Dial Transplant. 11:1996;2113-2115.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
29. Gaspari F, Mosconi L, Viganó G, et al. Measurement of GFR with a single intravenous injection of nonradioactive iothalamate. Kidney Int. 41:1992;1081-1084.
30. Pontremoli R, Sofia A, Tirotta A, et al. The deletion polymorphism of the angiotensin I converting enzyme gene is a risk factor for target organ damage in essential hypertension. J Am Soc Nephrol. 7:1996;2550-2558.
31. Keith NM, Wagener HP, Barker MW. Some different types of essental hypertension their course and prognosis . Am J Med Sci. 197:1939;332-343.
32. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens. 5:1992;207-209.
33. White WB, Pickering TG, Morganroth J, et al. A multicenter evaluation of the A and D TM-2420 ambulatory blood pressure recorder. Am J Hypertens. 4:1991;890-896.
34. Clark S, Fowlie S, Coats A, et al. Ambulatory blood pressure monitoring validation of the accuracy and reliability of the TM 2420 according to the AAMI recommendations . J Human Hypertens. 5:1991;77-82.
35. Mangili R, Deferrari G, Di Mario U, et al. Prevalence of hypertension and microalbuminuria in adult type 1 (insulin dependent) diabetic patients without renal failure in Italy validation of screening techniques to detect albuminuria . Acta Diabetol. 29:1992;156-166.
36. Mogensen CE, et al. Microalbuminuria an early marker of renal involvement in diabetes . Uremia Invest. 9:1985;85-95.
37. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
38. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography American Society of Echocardiography Committees . J Am Soc Echocardiogr. 55:1989;358-367.
39. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man anatomic validation of the method . Circulation. 55:1977;613-618.
40. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography Anatomic validation, standardization, and comparison to other methods . Hypertension. 9:(suppl II):1987;19-26.
41. Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 48:1995;820-826.
42. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia ultrasonographic assessment of intima-media thickness and plaque occurrence . Arterioscler Thromb. 13:1993;1404-1411.
43. Hricak H, Cruz C, Romansky R, et al. Renal parenchymal disease sonographic-histologic correlation . Radiology. 144:1982;141-147.
44. Mittelstaedt CA. General Ultrasound. 1992;883-1042 London, Churchill Livingstone.
45. Pedrinelli R, Di Bello V, Catapano G, et al. Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. Arterioscl Thromb. 13:1993;900-906.
46. Redon J, Gomez-Sanchez MA, Baldo E, et al. Microalbuminuria correlates with left ventricular hypertrophy in male hypertensive patients. J Hypertens. 9:1991;S148-S149.
47. Nosadini R, Semplicini A, Fioretto P, et al. Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension. Hypertension. 18:1991;191-198.
48. Bigazzi R, Bianchi S, Nenci R, et al. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Human Hypertens. 9:1995;827-833.
49. Veglio F, Provera E, Pinna G, et al. Renal resistive index after captopril test by echo-Doppler in essential hypertension. Am J Hypertens. 5:1992;431-436.
50. Veglio F, Frascisco M, Melchio R, et al. Assessment of renal resistance index after captopril test by doppler in essential and renovascular hypertension. Kidney Int. 48:1995;1611-1616.
51. Laragh JH. Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney Int. 44:1993;1163-1175.
52. Erley CM, Holzer M, Kramer BK, Riesler T. Renal haemodynamics and organ damage in young hypertensive patients with different plasma renin activities after ACE-inhibition. Nephrol Dial Transplant. 7:1992;216-220.
53. Williams DM, Luetscher JA. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med. 323:1990;1101-1106.
54. Laragh JH. The renin system and four lines of hypertension research. Hypertension. 20:1992;267-279.